SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
15588870
Source:
http://linkedlifedata.com/resource/pubmed/id/15588870
Search
Subject
(
54
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0032074
,
umls-concept:C0035820
,
umls-concept:C0152018
,
umls-concept:C1522449
pubmed:issue
3
pubmed:dateCreated
2004-12-13
pubmed:abstractText
To determine the additional value of FDG-positron emission tomography (PET) to optimize delineation of the clinical target volume (CTV) in patients with advanced esophageal carcinoma.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/8407192
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Fluorodeoxyglucose F18
,
http://linkedlifedata.com/resource/pubmed/chemical/Radiopharmaceuticals
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0167-8140
pubmed:author
pubmed-author:De WeverWalterW
,
pubmed-author:EctorsNadineN
,
pubmed-author:FlamenPatrickP
,
pubmed-author:HaustermansKarinK
,
pubmed-author:HieleMartinM
,
pubmed-author:LerutToniT
,
pubmed-author:Van CutsemEricE
,
pubmed-author:VriezeOlgaO
pubmed:issnType
Print
pubmed:volume
73
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
269-75
pubmed:meshHeading
pubmed-meshheading:15588870-Adult
,
pubmed-meshheading:15588870-Aged
,
pubmed-meshheading:15588870-Carcinoma
,
pubmed-meshheading:15588870-Endosonography
,
pubmed-meshheading:15588870-Esophageal Neoplasms
,
pubmed-meshheading:15588870-False Negative Reactions
,
pubmed-meshheading:15588870-Female
,
pubmed-meshheading:15588870-Fluorodeoxyglucose F18
,
pubmed-meshheading:15588870-Humans
,
pubmed-meshheading:15588870-Lymphatic Metastasis
,
pubmed-meshheading:15588870-Male
,
pubmed-meshheading:15588870-Middle Aged
,
pubmed-meshheading:15588870-Neoplasm Staging
,
pubmed-meshheading:15588870-Patient Care Planning
,
pubmed-meshheading:15588870-Positron-Emission Tomography
,
pubmed-meshheading:15588870-Prognosis
,
pubmed-meshheading:15588870-Radiopharmaceuticals
,
pubmed-meshheading:15588870-Retrospective Studies
,
pubmed-meshheading:15588870-Sensitivity and Specificity
,
pubmed-meshheading:15588870-Tomography, X-Ray Computed
pubmed:year
2004
pubmed:articleTitle
Is there a role for FGD-PET in radiotherapy planning in esophageal carcinoma?
pubmed:affiliation
Department of Radiation Oncology, University Hospital Gasthuisberg, UZ Gasthuisberg, Herestraat 49, B-3000 Leuven, Belgium.
pubmed:publicationType
Journal Article
,
Clinical Trial